A CLINICAL STUDY OF AN AGONIST - ANTAGONIST NALBUPHINE
• 2006
Publication Information
Authors
mohammed hisham abdulqader
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
N albuphine is an opioid against -antagonist of the phenanthrene
series .related to naloxone and oxymorphone. It is claimed to produce
good analgesia with fewer side effects than morphine (Wandless,
1987). The analgesic potency of nalbuphine is equal to that of morphine
on a milligram basis (Fragen and Caldwell, 1977).
The respiratory depressant capacity of intravenous nalbuphine a
potent analgesic of the narcotic antagonist type and morphine were
compared by Romagnoli and Keats, (1980) and they concluded that
nalbuphine in increments to a total of 60mg/kg, doses in excess of 30
mg/kg failed to increase respiratory depression beyond that induced by
morphine 20 mg/kg. A ceiling effect for respiratory depression
previously known to exist only for nalorphine was thereby
demonstrated to apply to nalbuphine.
series .related to naloxone and oxymorphone. It is claimed to produce
good analgesia with fewer side effects than morphine (Wandless,
1987). The analgesic potency of nalbuphine is equal to that of morphine
on a milligram basis (Fragen and Caldwell, 1977).
The respiratory depressant capacity of intravenous nalbuphine a
potent analgesic of the narcotic antagonist type and morphine were
compared by Romagnoli and Keats, (1980) and they concluded that
nalbuphine in increments to a total of 60mg/kg, doses in excess of 30
mg/kg failed to increase respiratory depression beyond that induced by
morphine 20 mg/kg. A ceiling effect for respiratory depression
previously known to exist only for nalorphine was thereby
demonstrated to apply to nalbuphine.
Staff Members - Benha University